Trial intelligence / Profile preview

Rivastigmine to prevent falls in Parkinson's disease

ISRCTN41639809Phase 3Completed

Sponsor
University of Bristol
Start
Sep 2019
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
01

Overview

Phase 3, randomised, double-blind trial in Parkinson's disease (PD) comparing Rivastigmine patch with Placebo patch (2 arms). Started Sep 2019; status: completed.

02

Drugs

rivastigmine
03

Conditions

Parkinson's disease (PD)

Beyond the preview

Go deeper on ISRCTN41639809.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN41639809.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call